Related Experiment Video
Updated: Apr 17, 2026

11:28
Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
42.2K
Serum hepcidin levels in Bulgarian population
Clinical Laboratory
|February 6, 2015
Summary
This study developed a reliable ELISA assay for measuring hepcidin, a key iron-regulating peptide. The assay established reference ranges for the Bulgarian population, aiding in diagnosing iron homeostasis disorders.
Area of Science:
- Biochemistry
- Immunology
- Clinical Chemistry
Background:
- Hepcidin is a crucial peptide regulating iron homeostasis.
- Quantifying hepcidin in human serum offers insights into iron metabolism disorders.
- This study focuses on hepcidin quantification and establishes reference ranges for the Bulgarian population.
Purpose of the Study:
- To develop and validate an ELISA immunoassay for human serum hepcidin quantification.
- To determine reference ranges for serum hepcidin levels in the Bulgarian population.
- To explore correlations between serum hepcidin and other iron status markers.
Main Methods:
- A sandwich ELISA using two monoclonal antibodies against hepcidin-25.
- Utilization of a pre-coated 96-well strip plate and recombinant hepcidin standard.
- Correlation analysis of ELISA results with ferritin, reticulocyte hemoglobin, transferrin, and iron levels.
Main Results:
- The developed sandwich ELISA demonstrated high specificity for hepcidin-25.
- Serum hepcidin reference ranges for the Bulgarian population were established as 3.052–37.750 μg/L.
- Significant positive correlations were observed between serum hepcidin and ferritin/reticulocyte hemoglobin; transferrin showed a negative correlation.
Conclusions:
- The sandwich ELISA offers a reliable, reproducible, and cost-effective method for measuring bioactive hepcidin.
- This assay is suitable for routine Bulgarian laboratory practice for hepcidin measurement.
- The findings contribute to understanding iron homeostasis and its regulation by hepcidin.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
266
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Hepatitis
63
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
364
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
364
Serum Studies: Renal Function Tests
658
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
658

